Patents by Inventor Didier Desmaele

Didier Desmaele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939577
    Abstract: The present invention relates to antisense RNAs targeting PMP22 and able to inhibit from 40% to 60% the expression of PMP22 in the cells and a pharmaceutical composition comprising thereof. The antisense RNAs are preferably siRNA and are preferably provided in the form of nanoparticles. The present invention also relates to the use of these antisense RNAs targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: March 26, 2024
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Liliane Massade, Charbel Massaad, Susan Boutary, Giorgia Maria Laura Urbinati, Patrick Couvreur, Didier Desmaële
  • Publication number: 20220002721
    Abstract: The present invention relates to antisense RNAs targeting PMP22 and able to inhibit from 40% to 60% the expression of PMP22 in the cells and a pharmaceutical composition comprising thereof. The antisense RNAs are preferably siRNA and are preferably provided in the form of nanoparticles. The present invention also relates to the use of these antisense RNAs targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 6, 2022
    Inventors: Liliane MASSADE, Charbel MASSAAD, Susan BOUTARY, Giorgia Maria Laura URBINATI, Patrick COUVREUR, Didier DESMAËLE
  • Patent number: 10213413
    Abstract: The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: February 26, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE, Institut Pasteur, UNIVERSITÉ PARIS-SUD
    Inventors: Christina Sizun, Stéphane Duquerroy, Jean-François Eleouet, Felix Rey, Anny Slama Schwok, Didier Desmaele, Patrick Couvreur, Bogdan Tarus
  • Patent number: 10125157
    Abstract: The present invention relates to novel derivatives of oxazaphosphorines that are pre-activated, to the methods for preparing same, to the pharmaceutical compositions containing same and to the therapeutic use thereof, in particular for treating cancer.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: November 13, 2018
    Assignee: INSTITUT GUSTAVE ROUSSY
    Inventors: Angelo Paci, Thierry Martens, Michael Rivard, Patrick Couvreur, Didier Desmaele, Joachim Caron
  • Patent number: 10098901
    Abstract: The present invention relates to novel derivatives of oxazaphosphorines, pharmaceutical compositions and therapeutic uses thereof, in particular for treating or preventing cancer.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: October 16, 2018
    Assignee: INSTITUT GUSTAVE ROUSSY
    Inventors: Angelo Paci, Thierry Martens, Michael Rivard, Didier Desmaele, Charles Skarbek, Patrick Couvreur
  • Publication number: 20170360752
    Abstract: The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
    Type: Application
    Filed: November 5, 2015
    Publication date: December 21, 2017
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE, Institut Pasteur, UNIVERSITÉ PARIS-SUD
    Inventors: Christina Sizun, Stéphane Duquerroy, Jean-François Eleouet, Felix Rey, Anny Slama Schwok, Didier Desmaele, Patrick Couvreur, Bogdan Tarus
  • Publication number: 20170071959
    Abstract: The present invention relates to novel derivatives of oxazaphosphorines, pharmaceutical compositions and therapeutic use thereof, in particular for treating or preventing cancer.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 16, 2017
    Inventors: ANGELO PACI, THIERRY MARTENS, MICHAEL RIVARD, DIDIER DESMAELE, CHARLES SKARBEK, PATRICK COUVREUR
  • Publication number: 20160333038
    Abstract: The present invention relates to novel derivatives of oxazaphosphorines that are pre-activated, to the methods for preparing same, to the pharmaceutical compositions containing same and to the therapeutic use thereof, in particular for treating cancer.
    Type: Application
    Filed: July 28, 2016
    Publication date: November 17, 2016
    Inventors: ANGELO PACI, THIERRY MARTENS, MICHAEL RIVARD, PATRICK COUVREUR, DIDIER DESMAELE, JOACHIM CARON
  • Patent number: 9428530
    Abstract: The present invention relates to novel derivatives of oxazaphosphorines that are pre-activated, to the methods for preparing same, to the pharmaceutical compositions containing same and to the therapeutic use thereof, in particular for treating cancer.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: August 30, 2016
    Assignee: INSTITUT GUSTAVE ROUSSY
    Inventors: Angelo Paci, Thierry Martens, Michael Rivard, Patrick Couvreur, Didier Desmaele, Joachim Caron
  • Patent number: 9295630
    Abstract: A complex formed of at least one molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or a derivative covalently bonded with at least one hydrocarbon radical with formula (A) as follows: wherein: •-m 1=1, 2, 3, 4, 5 or 6; •-m 2=0, 1, 2, 3, 4, 5 or 6; and represents the site of the bond with the molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or derivative.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: March 29, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS SUD XI
    Inventors: Patrick Couvreur, Fatima Zouhiri, Ruxandra Gref, Didier Desmaele
  • Publication number: 20150315220
    Abstract: The present invention relates to novel derivatives of oxazaphosphorines that are pre-activated, to the methods for preparing same, to the pharmaceutical compositions containing same and to the therapeutic use thereof, in particular for treating cancer.
    Type: Application
    Filed: July 2, 2015
    Publication date: November 5, 2015
    Inventors: ANGELO PACI, THIERRY MARTENS, MICHAEL RIVARD, PATRICK COUVREUR, DIDIER DESMAELE, JOACHIM CARON
  • Publication number: 20150045426
    Abstract: A complex formed of at least one molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or a derivative covalently bonded with at least one hydrocarbon radical with formula (A) as follows: wherein: •-m 1=1, 2, 3, 4, 5 or 6; •-m 2=0, 1, 2, 3, 4, 5 or 6; and represents the site of the bond with the molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or derivative.
    Type: Application
    Filed: March 14, 2013
    Publication date: February 12, 2015
    Inventors: Patrick Couvreur, Fatima Zouhiri, Ruxandra Gref, Didier Desmaele
  • Patent number: 8748414
    Abstract: The present invention relates to a complex made up of at least one molecule of statin or a derivative thereof, covalently bonded to at least one hydrocarbon radical including at least 18 carbon atoms and containing at least one 2-methyl-buta-2-ene unit, to nanoparticles of such a complex, and to a method for preparing same, said complex and/or said nanoparticles optionally being in the form of a lyophilizate. The present invention also relates to a pharmaceutical composition including at least one complex and/or nanoparticles such as previously defined. The invention finally relates to said complex and/or to said nanoparticles for the treatment and/or prevention of hyperlipemia and hypercholesterolemia.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: June 10, 2014
    Inventors: Patrick Couvreur, Didier Desmaele, Fat'ma Zouhiri, Reddy Harivardhan Lakkireddy
  • Publication number: 20110269830
    Abstract: The present invention relates to a complex made up of at least one molecule of statin or a derivative thereof, covalently bonded to at least one hydrocarbon radical including at least 18 carbon atoms and containing at least one 2-methyl-buta-2-ene unit, to nanoparticles of such a complex, and to a method for preparing same, said complex and/or said nanoparticles optionally being in the form of a lyophilisate. The present invention also relates to a pharmaceutical composition including at least one complex and/or nanoparticles such as previously defined. The invention finally relates to said complex and/or to said nanoparticles for the treatment and/or prevention of hyperlipemia and hypercholesterolemia.
    Type: Application
    Filed: October 28, 2009
    Publication date: November 3, 2011
    Inventors: Patrick Couvreur, Didier Desmaele, Fat'ma Zouhiri, Reddy Harivardhan Lakkireddy
  • Publication number: 20110184053
    Abstract: The invention relates to a complex formed by at least one molecule of nucleic acid comprising between 10 and 40 nucleotides, covalently coupled to at least one hydrocarbon compound that is at least C18 is hydrocarbon compound, having a squalene structure or a structure similar thereto.
    Type: Application
    Filed: May 14, 2009
    Publication date: July 28, 2011
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS SUD
    Inventors: Patrick Couvreur, Didier Desmaele, Mouna Raouane, Liliane Massade, Claude Malvy
  • Patent number: 7479497
    Abstract: The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase-inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: January 20, 2009
    Assignees: Bioalliance Pharma SA, Institut Gustave Roussy, Centre National de la Recherche Scientifique (C.N.R.S.), Inserm, Universite de Paris 11- Paris Sud
    Inventors: Aurélie Mousnier, Catherine Dargemont, Sabine Bonnenfant, Hervé Leh, Jean-François Mouscadet, Fatima Zouhiri, Jean D'Angelo, Didier Desmaele
  • Publication number: 20080161350
    Abstract: The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate, at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
    Type: Application
    Filed: March 5, 2008
    Publication date: July 3, 2008
    Inventors: Aurelia Mousnier, Catherine Dargemont, Sabine Bonnenfant, Herve Leh, Jean-Francois Mouscadet, Fatima Zouhiri, Jean D'Angelo, Didier Desmaele
  • Publication number: 20060148849
    Abstract: The invention relates to derivatives corresponding to formula I: in which X is an alkyl-(CH2)n— chain with n=0, 1 or 2, or O or N, Z is an aromatic which may contain heteroatoms chosen from O, N or S, as substitutions for the carbon atoms constituting said aromatic ring, this ring being substituted or otherwise with Rb, Rb represents 1 to 3 substituents chosen from —OH, —OR, —COOH, —COOR, —COH, —COR, —NH2, —NH(R), —NH(R,R?), —SH, —SR and CN, Ra is H or —(CH2)n?—Y, with n?=0, 1, 2 or 3 and Y and —CH3, —COOH, —COOR, —CN, —OH, —OR, SR, or an aryl group optionally substituted with Rb, R and R? represent a linear or branched alkyl chain of 1 to 4 C, and their pharmaceutically acceptable salts. Application as active ingredient of medicaments inhibiting retrovirus integrases.
    Type: Application
    Filed: March 1, 2006
    Publication date: July 6, 2006
    Inventors: Jean D'Angelo, Christophe Benard, Michele Danet, Marc Le Bret, Jean-Francois Mouscadet, Fatima Zouhiri, Marie Bayle, Didier Desmaele, Laurence Jeanson, Herve Leh, Frederic Subra
  • Patent number: 7064133
    Abstract: The invention relates to derivatives corresponding to formula I: in which X is an alkyl-(CH2)n— chain with n=0, 1 or 2, or O or N, Z is an aromatic which may contain heteroatoms chosen from O, N or S, as substitutions for the carbon atoms constituting said aromatic ring, this ring being substituted or otherwise with Rb, Rb represents 1 to 3 substituents chosen from —OH, —OR, —COOH, —COOR, —COH, —COR, —NH2, —NH(R), —NH(R,R?), —SH, —SR and CN, Ra is H or —(CH2)n?—Y, with n?=0, 1, 2 or 3 and Y and —CH3, —COOH, —COOR, —CN, —OH, —OR, SR, or an aryl group optionally substituted with Rb, R and R? represent a linear or branched alkyl chain of 1 to 4 C, and their pharmaceutically acceptable salts. Application as active ingredient of medicaments inhibiting retrovirus integrases.
    Type: Grant
    Filed: October 14, 2002
    Date of Patent: June 20, 2006
    Assignees: Bioalliance Pharma, Universite Paris SUD (Paris XI), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Gustave Roussy
    Inventors: Jean D'Angelo, Christophe Benard, Michele Danet, Marc Le Bret, Jean-Francois Mouscadet, Fatima Zouhiri, Marie Bayle, Didier Desmaele, Laurence Jeanson, Herve Leh, Frederic Subra
  • Publication number: 20050261336
    Abstract: The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase-inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
    Type: Application
    Filed: May 15, 2003
    Publication date: November 24, 2005
    Inventors: Aurelie Mousnier, Catherine Dargemont, Sabine Bonnenfant, Herve Leh, Jean-Francois Mouscadet, Catherine Dargemont, Sabine Bonnenfant, Herve Leh, Jean-Francois Mouscadet, Fatima Zouhiri, Jean D'Angelo, Didier Desmaele